ELSEVIRE Global Medical News
Search Elsevier Global Medical News
 
 
  Diamond Headache   American Academy of Neurology   American Headache Society
 
This news site is not sanctioned by, nor part of, the Diamond Headache Foundation, The American Academy of Neurology OR The American Headache Society.
News covering selected sessions related to migraine from 2008 medical conferences.
 
50th Annual Meeting of the American Headache Society Boston, Massachusetts June 26-29, 2008
Home
For many Migraineurs, Symptoms foretell onset of Headache
  Tertiary headache care now pays off in Better Health, Lower Costs Later
Deep Brain Stimulation for Chronic Headache Patients
  State-by-State Headache Care
Office based headache clinic eases burden on Emergency Departments
How Pain becomes Chronic Facilitation and Amplification
The Year's Top Clinical Advances
Role of Vascular Endothelium in Migraine
Physician Perspective on Patient Communication
Harold G. Wolff Lecture Award Recipient Warns Against Medication Overuse
Headache Care Providers urged to use open-ended Questions
International Classification of Headache Proves to be a Crucial Advance
Improved Communication Strategies can Aid Headache Treatment
Modulation of Headache Pain
Glial Cells and Pain Control
No evidence-based research supports idiopathic ntracranical Hypertension Treatments
Neurostimulation for Refractory Primary Headache
Occipital Nerve Stimulation for Refractory Primary Headache
 International Classification of Headache Proves to be a Crucial Advance
BY MAURY M. BREECHER
Contributing Writer
BOSTON — The international classification of headache disorders (ICHD-1 and 2) may be the most important advance in headache science for 50 years, said Dr. Jes Olesen at the 50th Annual Scientific Meeting of the American Headache Society on June 28.

“The IHS-Classification is one of the most important global milestones in the history of headache research for 50 years,” said Dr. Olesen of the Danish Headache Center at the University of Copenhagen, Denmark, who is a longtime pioneer and advocate of headache classification.

“A group of diseases without a system of classification is like a society without laws,” he said. “Operational diagnostic criteria are the crucial factor for present-day progress in headache research and therapy.”

The classification system is hierarchal, pointed out Dr. Olesen.

“You can code up to four levels and use it at different levels of sophistication,” he explained. “That means it can be used in general practice, in referral centers, it can be used for science. All you have to do is choose the level of sophistication you want to use.”

He asked, “What if we did not classify and define headaches?”

According to Dr. Olesen, the world would be a poorer place because headache epidemiology and cost data would be missing, clinical data would be limited to single patients, and no materials could be gathered for the study of disease mechanisms or for genetic studies, or for trials of acute and preventive drugs.

The classification system was designed for use both by research and clinical communities, Dr. Olsen pointed out. ICHD-1 and 2 have been crucially important for selecting patients for clinical trials, choosing patients for studies of headache mechanisms, and for encouraging the general acceptability of new treatments.

It has also been crucially important for describing convincingly the cost and burden of migraine to society.

“The politicians now have the data they need to recognize the terrible burden that headache places on society,” pointed out Dr. Olesen.

The IHS classification is exhaustive, all headaches can be classified according to its criteria.

“In addition to distinguishing the more than 100 different types of headaches, we gave precise diagnostic criteria for all the headache entities,” said Dr. Olesen. “We are able to diagnose headache in the same way throughout the United States and throughout the world.”

The classification system has been endorsed by all national headache societies, by the World Federation of Neurology and the World Health Organization (WHO). In fact, WHO accepted the major principles of IHS in its ICD 10 and, in 1997, published a separate guide containing the operational criteria of the classification system.
Copyright 2008 Elsevier Custom Conference Coverage. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the copyright owner. No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, the Publisher recommends that independent verification of diagnoses and drug dosages should be made. Opinions expressed in this publication are those of the original authors and do not necessarily reflect those of the Publisher, the sponsor, or the editors. Elsevier assumes no liability for any material published herein.
 
 
  Copyright ©2010 Elsevier/International Medical News Group
  5635 Fishers Lane, Suite 6000
Rockville, MD 20852
Rights reserved Clinical Neurology News Network